North America Cell Line Development Serum Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Type (Fetal Bovine Serum, Adult Bovine Serum, Porcine Serum, Horse Serum, Other Animal Serum); By Application (Bioproduction, Drug Discovery, Tissue Engineering and Regenerative Medicines, Toxicity Testing, Academic Research); and Country
Market Introduction
The cell line can be defined as cell culture, wherein the cells multiply by adapting in growing medium and space for growth. The cell line development serum market growth is mainly attributed to the serum as a source of growth and adhesion factors, lipids, hormones, and minerals for cells' culture in basal media. The serum serves as a carrier for enzymes, micronutrients, lipids, and trace elements into the cell and also regulates cell membrane permeability.
Get more information on this report :
Market Overview and Dynamics
The North America cell line development serum market is expected to reach US$ 502.91 Mn in 2027 from US$ 307.29 Mn in 2019. The market is estimated to grow with a CAGR of 6.4% from 2020-2027. Key factors that are driving growth of the North America cell line development serum market are increasing adoption of regenerative medicines, rising prevalence of cancer across the globe and increasing investments in R&D by pharmaceutical and biotechnology companies.
Key Market Segments
Based on type, the North America cell line development serum market is segmented into fetal bovine serum, porcine serum, adult bovine serum, horse serum, and other animal serum. The fetal bovine serum segment held a significant share of the market and is estimated to register the highest CAGR during the forecast period.
Based on application, the North America cell line development serum market is segmented into tissue engineering and regenerative medicines, academic research, drug discovery, toxicity testing, and bioproduction. In 2019, the bioproduction segment held the largest share of the market; whereas, the drug discovery segment is anticipated to register the highest CAGR in the market during the forecast period.
Major Sources and Companies Listed
Some of the primary and secondary sources associated with this report on the North America cell line development serum market are International Association for Stem Cell Application (ISSCA); American Type Culture Collection (ATCC); and World Health Organization (WHO); among others.
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of the North America cell line development serum market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the North America cell line development serum market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the North America cell line development serum market.
NORTH AMERICA CELL LINE DEVELOPMENT SERUM MARKET SEGMENTATION
By Type
- Fetal Bovine Serum
- Adult Bovine Serum
- Porcine Serum
- Horse Serum
- Other Animal Serum
- Bioproduction
- Drug Discovery
- Tissue Engineering and Regenerative Medicines
- Toxicity Testing
- Academic Research
By Country
- US
- Canada
- Mexico
Company Profiles
- Lonza
- Thermo Fisher Scientific Inc.
- Sigma-Aldrich Corporation (Merck KGaA)
- Cytiva (Danaher)
- Corning Incorporated
- European Collection of Cell Cultures (ECACC)
- WuXi AppTec
- American Type Culture Collection (ATCC)
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Cell Line Development Serum Market – By Type
1.3.2 North America Cell Line Development Serum Market – By Application
1.3.3 North America Cell Line Development Serum Market – By Geography
2. Cell Line Development Serum Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Cell Line Development Serum – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America
4.3 Expert Opinion
5. Cell Line Development Serum Market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Adoption of Regenerative Medicines
5.1.2 Rising R&D Investments and Collaborations Among Pharmaceutical and Biotechnology Companies
5.2 Key Restraints
5.2.1 Risk of Contamination, Misidentification, and Random Alternations in Cell Lines
5.3 Key Opportunities
5.3.1 Increasing Vaccine Production
5.4 Future Trends
5.4.1 Drug Development and Adoption of Novel Technologies for Cell Line Development
5.5 Impact Analysis
6. Cell Line Development Serum Market – North America Analysis
6.1 North America Cell Line Development Serum Market Revenue Forecast and Analysis
7. Cell Line Development Serum Market - Revenue and Forecasts to 2027 – Type
7.1 Overview
7.2 North America Cell Line Development Serum Market, by Type, 2019 & 2027 (% Share)
7.3 Fetal Bovine Serum
7.3.1 Overview
7.3.2 North America Fetal Bovine Serum Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Adult Bovine Serum
7.4.1 Overview
7.4.2 North America Adult Bovine Serum Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Porcine Serum
7.5.1 Overview
7.5.2 North America Porcine Serum Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Horse Serum
7.6.1 Overview
7.6.2 North America Horse Serum Market Revenue and Forecast to 2027 (US$ Mn)
7.7 Other Animal Serum
7.7.1 Overview
7.7.2 North America Other Animal Serum Market Revenue and Forecast to 2027 (US$ Mn)
8. Cell Line Development Serum Market Analysis and Forecasts to 2027 – Application
8.1 Overview
8.2 North America Cell Line Development Serum Market Share by Application 2019 & 2027 (%)
8.3 Drug Discovery
8.3.1 Overview
8.3.2 North America Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Bioproduction
8.4.1 Overview
8.4.2 North America Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Tissue Engineering and Regenerative Medicines
8.5.1 Overview
8.5.2 North America Tissue Engineering and Regenerative Medicines Market Revenue and Forecast to 2027 (US$ Mn)
8.6 Toxicity Testing
8.6.1 Overview
8.6.2 North America Toxicity Testing Revenue and Forecast to 2027 (US$ Mn)
8.7 Academic Research
8.7.1 Overview
8.7.2 North America Academic Research Revenue and Forecast to 2027 (US$ Mn)
9. Cell Line Development Serum Market Revenue and Forecast to 2027 – North America Analysis
9.1 North America Cell Line Development Serum Market, Revenue and Forecast to2027
9.1.1 Overview
9.1.2 North America Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.1.3 North America Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.1.4 North America Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.1.5 North America Cell Line Development Serum Market, Revenue and Forecast to 2027, By Country (%)
9.1.6 US: Cell Line Development Serum Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 US Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.1.6.2 US Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.1.6.3 US Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.1.7 Canada Cell Line Development Serum Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Canada Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.1.7.2 Canada Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.1.7.3 Canada Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
9.1.8 Mexico Cell Line Development Serum Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Mexico Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
9.1.8.2 Mexico Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
9.1.8.3 Mexico Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10. Impact Of COVID-19 Pandemic on North America Cell Line Development Serum Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
11. Company Profiles
11.1 Lonza
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Thermo Fisher Scientific Inc.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Sigma-Aldrich Corporation (Merck KGaA)
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Cytiva (Danaher)
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Corning Incorporated
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 European Collection of Cell Cultures (ECACC)
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 WuXi AppTec
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 American Type Culture Collection (ATCC)
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
12. Appendix
12.1 About the Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 2. North America Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 3. US Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 4. US Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 5. Canada Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 6. Canada Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 7. Mexico Cell Line Development Serum Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 8. Mexico Cell Line Development Serum Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 9. Glossary of Terms, Cell Line Development Serum Market
LIST OF FIGURES
Figure 1. Cell Line Development Serum Market Segmentation
Figure 2. Cell Line Development Serum Market Segmentation, By Country
Figure 3. North America Cell Line Development Serum Market Overview
Figure 4. Fetal Bovine Serum Segment Held Largest Share of Type Segment in Cell Line Development Serum Market
Figure 5. Global Cell Line Development Serum Market- Leading Country Markets (US$ Mn)
Figure 6. North America
Figure 7. Cell Line Development Serum Market Impact Analysis of Driver and Restraints
Figure 8. North America Cell Line Development Serum Market – Revenue Forecast and Analysis – 2019- 2027
Figure 9. North America Cell Line Development Serum Market, Type, 2019 & 2027 (% Share)
Figure 10. North America Fetal Bovine Serum Market Revenue and Forecast to 2027 (US$ Mn)
Figure 11. North America Adult Bovine Serum Market Revenue and Forecast to 2027 (US$ Mn)
Figure 12. North America Porcine Serum Market Revenue and Forecast to 2027 (US$ Mn)
Figure 13. North America Horse Serum Market Revenue and Forecast to 2027 (US$ Mn)
Figure 14. North America Other Animal Serum Market Revenue and Forecast to 2027 (US$ Mn)
Figure 15. North America Cell Line Development Serum Market Share by Application 2019 & 2027 (%)
Figure 16. North America Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
Figure 17. North America Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
Figure 18. North America Tissue and Regenerative Medicines Engineering Market Revenue and Forecast to 2027 (US$ Mn)
Figure 19. North America Toxicity Testing Market Revenue and Forecast to 2027 (US$ Mn)
Figure 20. North America Academic Research Market Revenue and Forecast to 2027 (US$ Mn)
Figure 21. North America Cell Line Development Serum Market Overview, By Country — 2019 (US$ Mn)
Figure 22. North America Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 23. North America Cell Line Development Serum Market, Revenue and Forecast to 2027, By Country (%)
Figure 24. US Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 25. Canada Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 26. Mexico Cell Line Development Serum Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 27. Impact of COVID-19 Pandemic in North American Country Markets
- Lonza
- Thermo Fisher Scientific Inc.
- Sigma-Aldrich Corporation (Merck KGaA)
- Cytiva (Danaher)
- Corning Incorporated
- European Collection of Cell Cultures (ECACC)
- WuXi AppTec
- American Type Culture Collection (ATCC)
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America cell line development serum market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America cell line development serum market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.